Clinical interest of point-of-care pharmacogenomic testing: clopidogrel behind warfarin

Author： Shahabi Payman Siest Gérard Visvikis-Siest Sophie

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.13, Iss.11, 2012-08, pp. : 1215-1218

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Exploring Point‐of‐Care Testing of Capillary Blood in Warfarin Management

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 38, Iss. 4, 2008-12 ,pp. : 300-304

John Wiley & Sons Inc

Access to resources Recommend Favorite

Point-of-Care Testing in Diabetes Care

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 2, 2011-02 ,pp. : 178-184

Bentham Science Publishers

Access to resources Recommend Favorite

Ethical considerations for pharmacogenomic testing in pediatric clinical care and research

By Moran Cassandra Thornburg Courtney D Barfield Raymond C

Pharmacogenomics, Vol. 12, Iss. 6, 2011-06 ,pp. : 889-895

Future Medicine

Access to resources Recommend Favorite

A Policy Model to Evaluate the Benefits, Risks and Costs of Warfarin Pharmacogenomic Testing

By Meckley Lisa M.

PharmacoEconomics, Vol. 28, Iss. 1, 2010-01 ,pp. : 61-74

Adis International

Access to resources Recommend Favorite

Evaluation of a new hemoglobin A1c analyzer for point‐of‐care testing

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 32, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite